ClinicalTrialsFinder

Carcinoma, Non-Small Cell Lung Clinical Trials in Bristol, Bristol, City of

1 recruitingBristol, Bristol, City of, United Kingdom

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Carcinoma, Non-Small Cell Lung
Merck Sharp & Dohme LLC680 enrolled225 locationsNCT06623422